[1] |
WU Y Q,WANG Z,XU H F,et al.Frequency of primary glomerular disease in northeastern China[J]. Braz J Med Biol Res,2011,44(8):810-813.
|
[2] |
陈香美. 临床诊疗指南-肾脏病学分册[M]. 北京:人民卫生出版社,2011:23-29.
|
[3] |
LIONAKI S,DEREBAIL V K,HOGAN S L,et al.Venous thromboembolism in patients with membranous nephropathy[J]. Clin J Am Soc Nephrol,2012,7(1):43-51.
|
[4] |
谌贻璞. 慢性肾脏病的定义与分期-从KDOQI到KDIGO:贡献与问题[J]. 临床肾脏病杂志,2011,11(1):4-6.
|
[5] |
PONTICELLI C,PASSERINI P.Management of idiopathic membranous nephropathy[J]. Expert Opin Pharmacother,2010,11(13):2163-2175.
|
[6] |
AL-AZZAWI H F,OBI O C,SAFI J,et al. Nephrotic syndrome-induced thromboembolism in adults[J]. Int J Crit Illn Inj Sci,2016,6(2):85-88.
|
[7] |
KERLIN B A,AYOOB R,SMOYER W E.Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease[J]. Clin J Am Soc Nephrol,2012,7(3):513-520.
|
[8] |
付阳,刘玉梅,金亚雄,等. 凝血与纤溶标志物在肺癌血栓栓塞患者中的临床应用价值研究[J]. 中国肺癌杂志,2018,21(8):583-587.
|
[9] |
MOORE H B,MOORE E E,GENZALEZ E,et al.Hyperfibrinolysis,physiologic fibrinolysis,and fibrinolysis shutdown:the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy[J]. J Trauma Acute Care Surg,2014,77(6):811-817.
|
[10] |
NIELSEN V G,MATIKA R W,LEY M L,et al.Tissue-type plasminogen activator-induced fibrinolysis is enhanced in patients with breast,lung,pancreas and colon cancer[J]. Blood Coagul Fibrinolysis,2014,25(3):248-253.
|
[11] |
高芳,张云娜,赵乃蕊,等. 不同程度亚临床甲状腺功能减退症患者止凝血相关指标变化的研究[J]. 检验医学,2018,33(2):110-114.
|
[12] |
POGGESI A,PASI M,PESCINI F,et al.Circulating biologic markers of endothelial dysfunction in cerebral small vessel disease:a review[J]. J Cereb Blood Flow Metab,2016,36(1):72-94.
|
[13] |
陈文欣,李强,薛赢俊,等. 恶性肿瘤患者凝血-纤溶系统标志物检测及其临床意义[J]. 检验医学,2018,33(8):722-726.
|
[14] |
弭雪. 出凝血分子标志物在弥散性血管内凝血中的动态变化及意义[D]. 青岛:山东大学,2017.
|
[15] |
黄智明. 血浆纤维蛋白原测定诊断脑血栓的价值探究[J]. 当代医学,2017,23(33):59-61.
|
[16] |
魏连波. 肾病综合征高凝状态形成机制与中医治疗[J].中华肾病研究电子杂志,2017,6(4):169-172.
|
[17] |
HAN L,LIU X,LI H,et al.Blood coagulation parameters and platelet indices:changes in normal and preeclamptic pregnancies and predictive values for preeclampsia[J]. PLoS One,2014,9(12):e114488.
|
[18] |
CHEN X W,LIU W T,WANG Y X,et al.Cyclopropanyldehydrocostunolide LJ attenuates high glucose-induced podocyte injury by suppressing RANKL/RANK-mediated NF-κB and MAPK signaling pathways[J]. J Diabetes Complications,2016,30(5):760-769.
|
[19] |
张鸿,梁顺,杜玥,等. 核因子κB受体活化因子通过TRPC6-NFATc1信号通路介导足细胞损伤[J]. 实用医学杂志,2019,35(1):25-29.
|
[20] |
王宏天. 纤维蛋白原与肾脏疾病[J]. 肾脏病与透析肾移植杂志,2016,25(5):466-469.
|